Skip to main content
. 2022 Mar 2;37(11):2547–2557. doi: 10.1007/s00467-022-05492-7

Fig. 2.

Fig. 2

The Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial schema. The FIT4KiD study is a randomized, double-blind, placebo-controlled, 12-month trial of 160 pediatric patients with CKD stages 3–4. It will test the hypothesis that, compared to placebo, ferric citrate will safely lower intact FGF23 levels. The study design includes a screening visit, baseline assessments, and post-randomization scheduled follow-up. Further details are provided in Table S1